Jessica Ley
Papers
1
Total Citations
5
H-Index
1
About
Dr. Jessica Ley is a leading clinical researcher in head and neck oncology, with a focus on human papillomavirus-positive oropharyngeal squamous-cell carcinoma (HPV+ OPSCC). Her work centers on refining treatment paradigms to reduce long-term toxicity without compromising survival outcomes. Dr. Ley’s most notable contribution is her leadership of a non-randomized, multi-arm Phase 2 trial investigating risk-directed, de-escalated adjuvant therapy for surgically resected locally advanced HPV+ OPSCC. This landmark study, published in 2024, demonstrated that tailored, less intensive post-operative regimens can maintain excellent disease control while minimizing side effects—a paradigm-shifting approach for patients with favorable prognosis. The work has already garnered 5 citations, signaling its rapid integration into clinical discourse. Dr. Ley’s research is instrumental in moving the field toward personalized, de-escalation strategies that prioritize quality of life, and her findings are shaping national treatment guidelines. Her dedication to balancing efficacy with survivorship makes her a pivotal figure in modern head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1